IN-VIVO DISPOSITION CHARACTERISTICS OF PLASMID DNA COMPLEXED WITH CATIONIC LIPOSOMES

被引:92
作者
MAHATO, RI [1 ]
KAWABATA, K [1 ]
TAKAKURA, Y [1 ]
HASHIDA, M [1 ]
机构
[1] KYOTO UNIV,FAC PHARMACEUT SCI,SAKYO KU,KYOTO 60601,JAPAN
关键词
CATIONIC LIPOSOME; GENE THERAPY; IN VIVO DISPOSITION; PLASMID DNA; TRANSFECTION;
D O I
10.3109/10611869509059214
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To control disposition and hence gene expression, we investigated the disposition characteristics of plasmid DNA complexed with the cationic liposomes Lipofectin(R) and LipofectACE(R) after intravenous injection in mice via the tail vein. The optimum ratios of DNA and liposome complexes were selected through in vitro cytotoxicity and transfection studies. The highest transfection was found at the DNA:liposome ratio of 1:5 w/w Hence, this ratio was used for in vivo disposition studies, and the distribution patterns were compared with that of naked pCAT. Following intravenous injection of [P-32] pCAT, radioactivity was rapidly eliminated from plasma and approximately 60% of the dose was taken up by the liver within 1.5 min. In the case of LipofectACE(R) samples, radioactivity elimination from plasma was equally rapid, but its accumulation was observed in both the liver (35%) and the lung (45%). For Lipofectin(R) samples, radioactivity was initially accumulated in both the liver (55%) and the lung (25%), but lung accumulation was not sustained beyond 5 min after administration. Both liposomal samples showed in vivo gene expression in the lung, heart, kidney and spleen, but not in the liver. Thus, the present study demonstrated that disposition and gene expression of pCAT can be controlled by complex formation with liposomes.
引用
收藏
页码:149 / 157
页数:9
相关论文
共 32 条
[1]   SYNTHETIC GENE-TRANSFER VECTORS [J].
BEHR, JP .
ACCOUNTS OF CHEMICAL RESEARCH, 1993, 26 (05) :274-278
[2]  
BERTLING WM, 1991, BIOTECHNOL APPL BIOC, V13, P390
[3]  
Brigham K. L., 1993, Journal of Liposome Research, V3, P31, DOI 10.3109/08982109309147442
[4]  
CURIEL DT, 1994, NAT IMMUN, V13, P141
[5]  
FELGNER P L, 1990, Advanced Drug Delivery Reviews, V5, P163, DOI 10.1016/0169-409X(90)90015-K
[6]  
FELGNER PL, 1993, LAB INVEST, V68, P1
[7]   LIPOFECTION - A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE [J].
FELGNER, PL ;
GADEK, TR ;
HOLM, M ;
ROMAN, R ;
CHAN, HW ;
WENZ, M ;
NORTHROP, JP ;
RINGOLD, GM ;
DANIELSEN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7413-7417
[8]   FACTORS INFLUENCING TRANSIENT EXPRESSION IN CYTOTOXIC T-CELLS FOLLOWING DEAE DEXTRAN-MEDIATED GENE-TRANSFER [J].
FREGEAU, CJ ;
BLEACKLEY, RC .
SOMATIC CELL AND MOLECULAR GENETICS, 1991, 17 (03) :239-257
[9]   PROGRESS TOWARD HUMAN-GENE THERAPY [J].
FRIEDMANN, T .
SCIENCE, 1989, 244 (4910) :1275-1281
[10]   THERAPEUTIC EFFECTS OF SUPEROXIDE-DISMUTASE DERIVATIVES MODIFIED WITH MONOSACCHARIDES OR POLYSACCHARIDES ON HEPATIC-INJURY INDUCED BY ISCHEMIA REPERFUSION [J].
FUJITA, T ;
FURITSU, H ;
NISHIKAWA, M ;
TAKAKURA, Y ;
SEZAKI, H ;
HASHIDA, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (01) :191-196